My watch list  

351 Current news from the ressort manufacturing


You can refine your search further. Select from the filter options on the left to narrow down your results.

Eppendorf significantly expands production site in Oldenburg


The Eppendorf Group is boosting its production capacity at its site in Oldenburg in Holstein by building two new production halls. Operations at the two sites will begin in the second half of 2020, significantly increasing the overall capacity of Eppendorf Polymere GmbH, a wholly owned subsidiary ...


Lonza Expands Bioconjugation Facility and Announces Approval of Third Commercial ADC


Lonza announced the start of expansion to its bioconjugation facility in Visp, Switzerland together with the successful commercial approval of a third antibody-drug-conjugate (ADC) produced at the site. Building on 12 years of experience in the exacting bioconjugation space, Lonza’s expansion ...


FUJIFILM Irvine Scientific constructs new cell culture media manufacturing site in Europe


FUJIFILM Irvine Scientific, Inc. announced plans to open a third manufacturing facility located in Tilburg, Netherlands. The company currently has sites in the United States and Japan. Fujifilm’s investment in this project demonstrates its commitment to accelerate development in bioproduction ...


Pharmaceutical Production with Reduced Waste

Platform technology for producing cephalosporin antibiotics


Antibiotics save countless human lives – modern medicine without them is unimaginable. The largest proportion by volume of industrially produced antibiotics today are cephalosporins, structural variants of the first antibiotic, penicillin. Unfortunately, their production generates a considerable ...


image description
Vetter Works Towards a Sustainable Energy Supply

All German sites of the pharmaceutical service provider will be supplied with green electricity moving forward


Vetter has reached another important milestone regarding sustainability. Beginning immediately, all German sites of the company will be supplied with only CO2 neutral energy from certified renewable energy sources. This action underlines the CDMO’s commitment to climate and environmental ...


Thermo Fisher Scientific to Invest $50 Million to Expand Bioproduction Capabilities


Thermo Fisher Scientific Inc. announced that it is investing more than $50 million in its global bioproduction capabilities to provide additional capacity for manufacturing single-use bioprocess container (BPC) systems. Thermo Fisher's single-use technologies are used for critical, sterile ...


image description
Merck Invests in Expansion of Manufacturing Capacity for Biotech Medicines

€150 million investment over the 2019-2023 period in manufacturing site at Aubonne, Switzerland


Merck announced an investment of €150 million (165 million Swiss francs) in its manufacturing site at Aubonne, Switzerland, to expand manufacturing capacity for its biotech medicines. The investment will cover a new building dedicated to Merck biotech medicines destined for more than 150 ...


BioMCN to produce renewable methanol with green hydrogen


Nouryon (formerly AkzoNobel Specialty Chemicals) and Gasunie have agreed to supply green hydrogen to BioMCN for the production of renewable methanol from CO2. The companies say it marks the next step in the sustainability of processes in the industry. Nouryon and Gasunie are currently ...


image description
SCHOTT to invest 300 million euros in pharmaceutical packaging business

Group to build new production facilities in Germany and China and expand capacity in India and Switzerland


The SCHOTT technology group is set to invest around 300 million euros in the next three years in the expansion of its core business of glass tubing as the starting material for pharmaceutical packaging as well as pharmaceutical packaging made of glass and polymer, reinforcing its strong belief in ...


Lonza to Establish Strategic Biomanufacturing Base in China


Lonza announced an agreement with GE Healthcare under which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou (CN). As the facility is part of a larger biomanufacturing initiative between GE Healthcare and Guangzhou Development District (GDD), the agreement will be finalized ...


Page 1 From 36
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE